Previous Close | 8.05 |
Open | 8.25 |
Bid | 8.30 x 400 |
Ask | 8.36 x 1100 |
Day's Range | 8.14 - 8.49 |
52 Week Range | 4.97 - 15.74 |
Volume | |
Avg. Volume | 5,557,346 |
Market Cap | 2.241B |
Beta (5Y Monthly) | 0.82 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.63 |
Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.57 |
The consensus price target hints at a 43.7% upside potential for Recursion Pharmaceuticals (RXRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.